Dixon Mitchell Investment Counsel Inc. Grows Stake in Danaher Corporation $DHR

Dixon Mitchell Investment Counsel Inc. boosted its stake in shares of Danaher Corporation (NYSE:DHR) by 2.1% during the 4th quarter, Holdings Channel.com reports. The firm owned 186,417 shares of the conglomerate’s stock after buying an additional 3,819 shares during the quarter. Danaher accounts for about 1.4% of Dixon Mitchell Investment Counsel Inc.’s holdings, making the stock its 26th largest position. Dixon Mitchell Investment Counsel Inc.’s holdings in Danaher were worth $42,756,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of DHR. Norges Bank purchased a new position in Danaher during the fourth quarter valued at $2,177,106,000. Viking Global Investors LP lifted its position in Danaher by 543.9% during the second quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate’s stock valued at $574,351,000 after purchasing an additional 2,455,994 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its position in Danaher by 104.7% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 4,333,056 shares of the conglomerate’s stock valued at $991,923,000 after purchasing an additional 2,216,789 shares in the last quarter. Generation Investment Management LLP lifted its position in Danaher by 34.0% during the third quarter. Generation Investment Management LLP now owns 6,654,666 shares of the conglomerate’s stock valued at $1,319,354,000 after purchasing an additional 1,689,020 shares in the last quarter. Finally, Capital International Investors lifted its position in Danaher by 8.9% during the fourth quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock valued at $4,177,386,000 after purchasing an additional 1,487,768 shares in the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Key Stories Impacting Danaher

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: Danaher closed its $9.9 billion acquisition of Masimo, expanding its diagnostics and patient-monitoring portfolio with AI-enabled sensor technologies that could support longer-term growth. Danaher Boosts Product Portfolio With the Acquisition of Masimo
• Positive Sentiment: Cepheid, a Danaher company, donated Xpert Hemorrhagic Fever panel tests to support Ebola outbreak response in Africa, highlighting the company’s diagnostic relevance and public-health role. Cepheid Delivers Xpert Hemorrhagic Fever Panel Tests to Africa
• Positive Sentiment: Analysts noted strong performance in Danaher’s biotechnology unit, with bioprocessing demand and equipment orders rising, which supports the company’s 2026 growth outlook. Strong Performance Continues at DHR’s Biotechnology Unit: What’s Next?

Danaher Price Performance

DHR stock opened at $179.95 on Friday. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The company has a fifty day simple moving average of $180.93 and a two-hundred day simple moving average of $204.78. The firm has a market capitalization of $127.37 billion, a P/E ratio of 34.81, a price-to-earnings-growth ratio of 2.40 and a beta of 0.81.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating the consensus estimate of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The business had revenue of $5.95 billion during the quarter, compared to analyst estimates of $6 billion. During the same quarter last year, the business earned $1.88 earnings per share. Danaher’s quarterly revenue was up 3.7% compared to the same quarter last year. Analysts anticipate that Danaher Corporation will post 8.45 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s payout ratio is presently 30.95%.

Analysts Set New Price Targets

DHR has been the topic of several analyst reports. Citigroup initiated coverage on Danaher in a research report on Tuesday, May 26th. They set a “buy” rating and a $230.00 target price on the stock. Morgan Stanley lowered their target price on Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Wall Street Zen downgraded Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. The Goldman Sachs Group lowered their target price on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Monday, April 13th. Finally, Piper Sandler began coverage on Danaher in a research report on Thursday. They set a “neutral” rating and a $200.00 target price on the stock. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $233.61.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.